Raportul
Analize aprofundate ale finanțării companiilor, strategiilor de creștere și informații de piață de la cele mai inovatoare afaceri din lume
53 rapoarte și mai multe
Ginkgo Bioworks transforms synthetic biology industry with $350M IPO at $15B valuation
Ginkgo Bioworks achieves $15B valuation through $350M IPO funding, establishing dominance in the synthetic biology market with innovative synthetic biology platform for organism design and manufacturing.
BioSynthetic Materials Raises $720M Series D for Revolutionary Synthetic Biology Technology
BioSynthetic Materials secures $720M in Series D funding at $10.8B valuation to pioneer breakthrough synthetic biology technology.
Zymergen transforms synthetic biology industry with $300M Series C at $3.2B valuation
Zymergen achieves $3.2B valuation through $300M Series C funding, establishing dominance in the synthetic biology market with innovative biomanufacturing platform for materials and chemicals.
Twist Bioscience secures $120M Series D for biotech innovation
Twist Bioscience raises $120M in Series D funding to advance its synthetic biology company manufacturing dna sequences and accelerate market growth.
BioSynth Labs raises $380M Series B in September 2025 funding round
BioSynth Labs secures $380M in Series B funding in September 2025, reaching $3.2B valuation to advance its synthetic biology platform for sustainable chemical manufacturing.
CanSino Biologics Headquarters - Office Location & Address
Discover CanSino Biologics's headquarters at West Area of TEDA, Tianjin, 300457. Vaccine research and development. Learn about the office facilities and work environment.
China Biologic Products Headquarters - Office Location & Address
Discover China Biologic Products's headquarters at 17 Science Park Rd, Beijing, 100176. Plasma-based biopharmaceutical products. Learn about the office facilities and work environment.
Absci Raises $125M Series D
AI-powered drug discovery platform using deep learning and synthetic biology to design novel antibodies and biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Afișare 9 rapoarte • Pagina 1 • Categorie: all
Rămâneți înaintea pieței
Primiți perspective săptămânale în inbox. Fără spam, doar inteligență.